Jefferies Remains Neutral on Bath & Body Works, Inc. (BBWI)

Bath & Body Works, Inc. (NYSE:BBWI) is among the best US stocks to buy under $20. On November 21, Jefferies analyst trimmed the price target on Bath & Body Works, Inc. (NYSE:BBWI) to $16.00 from $28.50, while maintaining an ‘Hold’ rating on the stock. The firm highlighted the company’s recent third-quarter sales and EPS that underperformed estimates. Not only that, management revised the company’s full-year guidance downward.

Jefferies warned that sustained macroeconomic headwinds continue to impact sales, prompting the postponement of initiatives to support the business. This means Bath & Body Works, Inc. (NYSE:BBWI) will witness only limited growth above forecasts for now, the analyst added.

On the same day, UBS also reduced its price target on Bath & Body Works, Inc. (NYSE:BBWI) to $17.00 from $32.00, while keeping its rating ‘Neutral.’ This pessimism comes right after the company announced its earnings on November 20, which the firm says reported trends “much worse than previously thought.” UBS further notes that the company is currently entering a “multiyear process” of business recovery.

With this view in mind, UBS lowered its fiscal year 2025-27 estimates by nearly 29-30%, expecting a -1% five-year EPS compound annual growth rate for Bath & Body Works, Inc. (NYSE:BBWI), a considerable dip from its previous +6% estimate.

Bath & Body Works, Inc. (NYSE:BBWI) is an Ohio-based specialty retailer of products, such as home fragrance, personal and body care, and soaps. Founded in 1963, the company operates under various names like Bath & Body Works and White Barn.

READ NEXT: The Best and Worst Dow Stocks for the Next 12 Months and 10 Unstoppable Stocks That Could Double Your Money.

Disclosure: None.